Orthorexia Nervosa in Postmenopausal Osteoporosis
Recruiting · NCT06947213 · Observational (researchers observe without assigning treatment) · Lead sponsor: Beylikduzu State Hospital
View the official record on ClinicalTrials.gov →What this trial is about
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.
Who can take part
Inclusion criteria
- Women between 55-75 years
- Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
- Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
- Willingness to participate and provision of written informed consent.
Exclusion criteria
- Refusal to participate in the study.
- Diagnosed psychiatric disorders.
- Cognitive impairment.
- Presence of malignancy.
- Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
- Use of glucocorticoids.
- Use of medications affecting mood.
Where it is running
1 location listed.
- Beylikdüzü State Hospital - Istanbul, Turkey (Türkiye)